STIMPOD NMS450 Nerve Stimulator
Stimulator, Nerve, Battery-Powered. 510(k) K213049, from Xavant Technology (Pty), Ltd. (Pretoria, ZA). Product code BXN, class 2.
As of Nov 21, 2026, K213049 is an FDA 510(k) held by Xavant Technology (Pty), Ltd., substantially equivalent on Oct 16, 2022 after 389 days, with no recalls tied to it in FDA's recall database.
- Review time: 389 days
- Recalls: 0
This device is a nerve stimulation device designed to be used by an anesthetist during: 1. General anesthesia, for the purpose of establishing the efficacy of a Neuromuscular Blocking Agent using non-invasive surface electrodes. 2. Regional anesthesia, for the purpose of: i. nerve mapping using the non-invasive Nerve Mapping Probe (supplied) ii. nerve locating using invasive needles (not supplied)
- Stimpod NMS450 Nerve StimulatorK102084 · Xavant Technology (Pty), Ltd. · Dec 16, 2010
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 22, 2021
- Review panel
- Anesthesiology
- Regulation
- 21 CFR 868.2775
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files